Paxlovid does not increase risk of COVID reinfection: study

Published Date: 16 Feb 2023

Although there are concerns that the use of Paxlovid increases the risk of COVID-19 returning, the results are clear.

Read Full News

Latest News

Pediatricians Sidestep Trump CDC Vaccine Guidance

Growing distrust of the CDC has prompted pediatricians and health departments to seek independent vaccine guidance.

Antibody Drug Shows Promise in Refractory Lymphoma

Loncastuximab tesirine shows promise for patients with diffuse large B-cell lymphoma after multiple treatments, including relapse following chimeric antigen receptor T-cell therapy.

When Cost-Saving Software Undermines GP Prescribing

As part of the BMA's collective action, GPs are switching off prescribing prompts that critics say put cost ahead of patient care.

Acalabrutinib May Offer Durable Results in CLL Treatment

Acalabrutinib monotherapy offers sustained progression-free and overall survival in treatment-naive chronic lymphocytic leukemia.

Air Conditioning or Viruses: What’s Causing Summer Colds?

Air conditioning may affect indoor air quality and comfort, but clinicians should focus on viral transmission and heat-related illness when advising patients.

How Financial Toxicity Undermines Patient Trust

Patients hand over their lives in a single meeting. Dr Emil Lou discusses why financial strain is the single biggest threat to that fragile trust.

Todays Updates

Dupilumab Improves Allergic Fungal Rhinosinusitis Outcomes

Dupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.

Fecal Transplant Raises Peanut Tolerance

Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.

Dupilumab Shows Long-Term Benefits in CRSwNP

Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.

Childhood Lupus: High Disease Activity Persists in Adulthood

Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.

First Dust Mite Immunotherapy Cleared for Scotland

Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.

Todays Updates

Dupilumab Improves Allergic Fungal Rhinosinusitis Outcomes

Dupilumab significantly improves sinus opacification and disease burden in patients with allergic fungal rhinosinusitis.

Fecal Transplant Raises Peanut Tolerance

Oral fecal microbiota transplant raises the amount of peanut that some highly allergic adults can tolerate, serving as proof of concept for microbiome-based food allergy therapy.

Dupilumab Shows Long-Term Benefits in CRSwNP

Dupilumab yields sustained benefits in terms of nasal congestion, sense of smell, and quality of life in patients with CRSwNP over 24 months in a real-world global registry.

Childhood Lupus: High Disease Activity Persists in Adulthood

Adults with childhood-onset systemic lupus erythematosus face a strikingly different disease trajectory than those diagnosed later in life, spending less time in the low disease activity state.

First Dust Mite Immunotherapy Cleared for Scotland

Acarizax is now the first house dust mite immunotherapy accepted by the SMC for patients with persistent allergic rhinitis.

Latest News

Growing distrust of the CDC has prompted pediatricians and health departments to seek independent vaccine guidance.

Loncastuximab tesirine shows promise for patients with diffuse large B-cell lymphoma after multiple treatments, including relapse following chimeric antigen receptor T-cell therapy.

As part of the BMA's collective action, GPs are switching off prescribing prompts that critics say put cost ahead of patient care.

Acalabrutinib monotherapy offers sustained progression-free and overall survival in treatment-naive chronic lymphocytic leukemia.

Air conditioning may affect indoor air quality and comfort, but clinicians should focus on viral transmission and heat-related illness when advising patients.

Patients hand over their lives in a single meeting. Dr Emil Lou discusses why financial strain is the single biggest threat to that fragile trust.

News All Time

Stem Cell Transplant Boosts Survival in Primary CNS Lymphoma

Among patients with primary CNS lymphoma who respond to induction therapy, high-dose chemotherapy with stem cell transplant improves survival compared with nonmyeloablative chemotherapy.

Stop ‘Nexting’ Patients and Start Mind Wandering Instead

Nexting is driven by schedule stress, but genuine mind wandering is a cognitive asset. Here’s how to tell the difference and stay present with patients.

FDA Neurology Roundup: July 2026

A monthly snapshot of FDA activity involving therapies for the prevention and treatment of neurologic diseases.

Does ERBB2-Low Predict Poor Survival in Gastric Cancer?

Baseline clinical characteristics, rather than ERBB2 status, appeared to explain the survival differences observed between patients with ERBB2-low and ERBB2-null advanced gastric cancer.

Otitis Media Consults, Antibiotic Rx Rebound Post-Pandemic

Childhood otitis media consultation rates and consultations with antibiotic prescribing, which fell sharply during the COVID pandemic, have recovered post-pandemic in the UK and Netherlands.

The Promise and Perils of Alternative Cancer Clinics

One family's experience reflects a growing issue in oncology: a hope that alternative therapies can succeed where conventional medicine has fallen short, a hope that can come with big risks.

NICE Criteria Miss 95% of Under-50s at Breast Cancer Risk

Full multifactorial assessment flagged 34.8% of women who developed breast cancer within a decade, against 4.4% under current NICE criteria.

Clearance of Hepatitis B Antigen Tied to Better Outcomes

Older age, low hepatitis B virus load, and loss of hepatitis B e antigen are linked to clearance of hepatitis B surface antigen, which predicts better long-term liver outcomes.

Who Owns Medical Knowledge Now?

Doctors are no longer the only source of medical knowledge in the room, and the future may depend on who preserves the most humanity.

Why Some Teens Are Vulnerable to Substance Use Disorders

Emerging research suggests vulnerability to substance use disorders may begin before the first drink or drug. Drs Leslie A. Hulvershorn and Paola P. Mattey Mora explain why.

FDA Psychiatry Roundup: July 2026

A monthly snapshot of FDA activity involving therapies used in the prevention, diagnosis, and treatment of psychiatric conditions.

The ‘Fourth Pillar of Cancer Care’ That’s Often Missed

Oncology has shown quitting tobacco improves outcomes. Now the field must learn how to incorporate cessation treatment alongside other cancer treatments.

Biosimilar Rituximab Matches Originator in ANCA Vasculitis

At 6 months, rituximab biosimilars show remission rates comparable to the originator in patients with granulomatosis with polyangiitis and microscopic polyangiitis, with no concerning safety signals.

Brain Health Lessons From Blue Zones

Kathrin LaFaver interviews fellow neurologist Aleksandra Pikula, who completed the Blue Zones certification from the American College of Lifestyle medicine on strategies for healthy brain aging.

Only 1 in 5 Second-Level Medicare Drug Appeals Succeed

Cancer drugs prescribed on-label but denied for coverage criteria are overturned most often on independent review, raising concerns about avoidable barriers to care.

MRI Models Predict Early HCC Recurrence After Resection

Two MRI-based models effectively predicted very early hepatocellular carcinoma recurrence among patients with single BCLC stage 0/A disease following curative resection.

Recommended News For You

Parents, teachers at Missouri school want answers after string of cancer diagnoses

Smart exercise planning could boost recovery for people with cancer

Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study

Admissions, medical schools, costs, and eligibility requirements information for FNB Onco-Anesthesia.

Survival rates for incurable larynx cancer investigated for first time

How cancer misinformation exploits the way we think

Imfinzi + Imjudo, EU approved for patients with advanced lung cancer and non-small cell lung cancer: AstraZeneca

Recommended Articles For You

Ferroptosis as a Therapeutic Target in Cancer 

Surprising Symptoms of Prostate Cancer: What You Need to Know 

Public Health Strategies for Expanding Early Support Systems in Blood Disorders 

Unlocking the Potential of Palbociclib: A Comprehensive Overview 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

When Should Immunocompromised Individuals Receive a COVID Booster?

2.

Older Adults With Advanced Cancer Prioritize Quality of Life

3.

FDA Approves Next-Gen Agent for Mantle Cell Lymphoma

4.

Can MRI Curb Chemo Overtreatment in Breast Cancer?

5.

Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer

1.

Navigating the Stages of Thyroid Cancer: A Guide for Patients

2.

Subchorionic Hematoma: Causes, Symptoms, and Treatment 

3.

Advanced Advances in Oncology for Healthcare Excellence

4.

Polyposis Syndrome: Causes, Symptoms, and Treatment Options

5.

Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

1.

Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- Summarization of the New Perspective

2.

Thromboprophylaxis In Medical Settings

3.

Current Scenario of Cancer- Q&A Session to Close the Gap

4.

Newer Immunotherapies for Myeloma- A Comprehensive Overview

5.

Dissecting Molecular differences between EGFR Exon 19 deletion and Exon 21 L858R Mutations

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot